Amgen has identified humor as the way to connect with psoriasis patients. In a space dominated by serious ads about the burdens of psoriasis, the Big Biotech has put a lighthearted spin on the ...

Please provide your email address to receive an email when new articles are posted on . Otezla is now available in the U.S. to treat children and adolescents with moderate to severe plaque psoriasis.

Amgen Inc. AMGN announced that it has completed the previously-announced acquisition of Celgene’s blockbuster psoriasis drug Otezla, which the latter had to divest in order to complete its merger with ...